Investors' belief in the company's poor revenue performance is likely causing its low P/S ratio. The company's bleak revenue outlook is contributing to its low P/S. These conditions form a barrier for the share price at these levels.
Shanghai Henlius Biotech's statutory profit might not fully reflect the company's underlying earning capacity due to unusual item expense. The change from loss to profit is a positive turn for the firm.
复宏汉霖股票讨论区
UOBKH: Healthcare – China (Overweight)
UOBKH: Healthcare – China (Overweight) - Alpha Edge Investing
$药明生物(02269.HK)$$药明康德(02359.HK)$$信达生物(01801.HK)$$启明医疗-B(02500.HK)$$复宏汉霖(02696.HK)$$爱尔眼科(300015.SZ)$$迈瑞医疗(300760.SZ)$
专栏港股收评:三大指数齐跌,恒指下挫近300点,濠赌股逆势走强
港股再度表现低迷, $恒生科技指数(800700.HK)$ 午后一度大跌2.8%,收跌2.39%报4102.02点, $恒生指数(800000.HK)$ 、 $国企指数(800100.HK)$ 分别跌1.37%和1.63%,恒指下挫近300点。南下资金全日净流入45.32亿港元,大市成交额缩量至不足千亿港元。
盘面上,大型科技股全线下跌, $快手-W(01024.HK)$ 、 $小米集团-W(01810.HK)$ 跌超4%, $阿里巴巴(BABA.US)$ 、 $京东集团-SW(09618.HK)$ 、 $腾讯控股(00700.HK)$ 、 $网易-S(09999.HK)$ 、 $百度集团-SW(09888.HK)$ 皆跌超2%, $美团-W(03690.HK)$ 逆势收红;中信预计行业Q2销售速度将略...
DBS: China Healthcare Sector – Pharmaceutical Packaging
$微创医疗(00853.HK)$$威高股份(01066.HK)$$石药集团(01093.HK)$$国药控股(01099.HK)$$华润医疗(01515.HK)$$康臣药业(01681.HK)$$春立医疗(01858.HK)$$环球医疗(02666.HK)$$复宏汉霖(02696.HK)$$创业慧康(300451.SZ)$$柳药集团(603368.SH)$$百济神州(06160.HK)$
DBS: China Biotech Sector
$百济神州(06160.HK)$$石药集团(01093.HK)$$复宏汉霖(02696.HK)$$微创医疗(00853.HK)$$威高股份(01066.HK)$$国药控股(01099.HK)$$华润医疗(01515.HK)$$康臣药业(01681.HK)$$春立医疗(01858.HK)$$环球医疗(02666.HK)$$复宏汉霖(02696.HK)$$创业慧康(300451.SZ)$$柳药集团(603368.SH)$$百济神州(06160.HK)$
暂无评论